Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report  
Real-time Quote. Real-time Tradegate - 11/14 10:06:47 am
105.775 EUR   -3.62%
05:26aEUROPE : Daimler drives European shares lower as data stirs more fears
RE
03:43aMerck KGaA raises 2019 guidance after Versum takeover
RE
01:37aMERCK : 3Q Net Profit, Revenue Rose
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Germany's Merck KGaA Acquires FloDesign Sonics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/10/2019 | 09:48am EST

By Kim Richters

Germany's Merck KGaA (MRK.XE) said on Thursday that it acquired U.S. company FloDesign Sonics.

FloDesign Sonics provides technology that enables the manipulation of cells with ultrasonic waves and that is used in cell and gene therapy manufacturing, pharmaceutical company Merck said.

The "acquisition is a strategic fit for Merck, strengthening the ability alongside pharmaceutical manufacturers to advance cell-based therapies to patients," the company said.

The company didn't comment on the financial details of the deal.

Write to Kim Richters at kim.richters@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
MERCK AND COMPANY 0.83% 84.82 Delayed Quote.11.01%
MERCK KGAA -2.05% 107 Delayed Quote.21.97%
MERCK LTD -1.33% 4310.6 End-of-day quote.36.84%
MRK HOLDINGS INC. 1.06% 191 End-of-day quote.37.41%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
05:26aEUROPE : Daimler drives European shares lower as data stirs more fears
RE
03:43aMerck KGaA raises 2019 guidance after Versum takeover
RE
01:37aMERCK : 3Q Net Profit, Revenue Rose
DJ
11/12MERCK : Licenses CRISPR Gene-Editing Technology to Evotec
DJ
11/11MERCK KOMMANDITGESELLSCHAFT AUF AKTI : quaterly earnings release
11/11PFIZER : EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 T..
AQ
11/08PFIZER, MERCK KGAA : Bavencio Misses Main Endpoint in Gastric Cancer Study
DJ
11/08MERCK : Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastr..
PU
11/07OBSEVA : Ending Nolasiban IVF Program As Phase 3 Study Fails
DJ
11/01Amgen To Invest In Chinese Biotech -- WSJ
DJ
More news
Financials (EUR)
Sales 2019 15 705 M
EBIT 2019 2 201 M
Net income 2019 1 489 M
Debt 2019 4 876 M
Yield 2019 1,21%
P/E ratio 2019 32,2x
P/E ratio 2020 25,2x
EV / Sales2019 3,35x
EV / Sales2020 3,13x
Capitalization 47 717 M
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 106,01  €
Last Close Price 109,75  €
Spread / Highest target 21,4%
Spread / Average Target -3,41%
Spread / Lowest Target -22,6%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA21.97%52 505
KYOWA KIRIN CO., LTD.0.69%10 074
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD24.18%9 025
JAZZ PHARMACEUTICALS PLC7.54%7 542
BETTA PHARMACEUTICALS CO LTD--.--%3 760
YUHAN CORP--.--%2 135